Small Cap Feast

Small Cap Feast – 28 October 2019

Set Menu AIM:

Total number of AIM Companies (Incl Susp): 876

Total number of AIM Companies trading: *
* As at 28 October 2019

Set Menu NEX Growth:

Total number of NEX Growth Market Companies (Incl Susp): 86*

Total number of NEX Growth Market Companies trading: *
* As at 28 October 2019

Set Menu Standard List:

Total number of Standard List Companies (Incl Susp): *

Total number of Standard List Companies trading: *
* As at 28 October 2019

Dish of the Day:

No Joiners Today

Off the Menu:

No Leavers Today

Dish of the Day:

No Joiners Today

Off the Menu:

No Leavers Today

What’s Cooking in the IPO Kitchen?

Main Market premium

African Export-Import Bank a supranational financial institution whose purpose is to facilitate, promote and expand intra- and extra- African trade, of its potential intention to publish a registration document, the Bank hereby confirms its intention to proceed with an Initial Public Offering. The GDRs are expected to be admitted to the standard listing segment of the Official List of the FCA and to trading on the Main Market of the LSE.

DNEG Limited intends to apply for admission of its Shares to the premium listing segment of the Official List of the FCA and to trading on the London Stock Exchange’s main market for listed securities. The Offer will be comprised of new Shares to be issued by the Company (to raise expected gross proceeds of £150m). Admission is expected to take place in November 2019.

Breakfast Buffet

Benchmark Hlgs (BMK) 48.5p £271m

Benchmark, the aquaculture health, nutrition and genetics business, announces that it will receive US$8.75m from AquaChile, representing the second and final payment under the joint venture dissolution agreement. Payment is due within 5 days of signing.

As part of this agreement the Company has completed the transfer of ownership of the Ensenada facility, which gives Benchmark control of the salmon breeding operation previously belonging to the joint venture. The Company has received the IP rights, genetics stock and biomass in the joint venture.

The Ensenada facility is a highly bio-secure hatchery situated in the “Los Lagos” region in Chile, with good access to spring water required for the production of high-quality eyed eggs suitable for the Chilean industry. The Ensenada facility is being adapted to be suitable for maturation of broodstock, spawning and fertilisation of eggs, and it is expected that the first eggs from the new facility will be available in H1 2021.

IXICO (IXI) 74.5p £32.6m

IXICO plc, the AI data analytics company delivering insights in neuroscience, announces three new biopharma contracts and the appointment of Lammert Albers as Chief Business Officer effective immediately.

The new contracts are:

A start up agreement with a new client for a new multi-study programme in Progressive Supranuclear Palsy (PSP), with an initial value of c£0.4m, over 12 months

A c£0.35m, three-year, expansion of an existing study to add a significant patient cohort in China

A c£0.45m, two-year, new client contract to support a Phase IV study for a US biotech client, exploring a new application for a marketed drug for mental health

The Company has been contracted to initiate work on a new PSP programme for a client, ahead of patient enrolment later in 2019. The first study in the programme has a value of approximately £0.4m and is expected to lead to a larger programme of work in early 2020.

Cerillion (CER) 188.5p £55.6m

Cerillion, the billing, charging and customer relationship management (“CRM”) software solutions provider, provides a trading update for its financial year ended 30 September 2019.

Results for the year are expected to be in line with market expectations, with revenues rising by 8% to c. £18.7m (2018: £17.4m) and adjusted EBITDA up by 14% to c. £4.5m (2018: £3.9). The Company’s net cash position has grown strongly year-on-year and is expected to stand at c. £5.0m (2018: £2.5m), which is ahead of market forecasts.

As anticipated in the Company’s Interim Results in May, trading has been significantly second half weighted this year due to the timing of contract closures. The second half of the year saw Cerillion sign three major contracts, with these new wins continuing the trend towards larger deal sizes.  Over the year, major new contracts were secured from all the Company’s key international geographies, Europe, the Americas and Asia-Pacific.”

Autins Group (AUTG) 20.5p £8.1m

Autins Group, a leading designer, manufacturer and supplier of acoustic and thermal insulation solutions for the automotive sector, provides the following update on trading for the year ended 30 September 2019.

The Board expects to report FY19 results in line with market expectations.

The extensive management actions employed to reduce costs and increase operational efficiency have successfully delivered improved profit margins. The Group is well placed with sufficient capacity to take advantage of the many opportunities in its pipeline to grow and diversify the business.

Sales to customers outside of UK are progressing well and in this regard, the Board is pleased with the developments made by Neptune, the Group’s lightweight, high performance material, in securing multiple new business client wins and with production levels ramping up towards the end of FY19, which has continued in the new financial year.”

Scholium Group (SCHO) 39.5p £5.1m

The Group has made a small profit during the period, which represents a considerable improvement compared with the loss incurred during the six months ended 30 September 2018.

The Group’s trading has continued the progress made in the second half of the financial year ended 31 March 2019. Mayfair Philatelics is now operating a fuller auction programme, and traded at breakeven for the six months to 30 September 2019 compared with a loss of £79k in the corresponding prior period.

BlueRock Diamonds (BRD) 112.5p £3.9m

BlueRock Diamonds plc, the AIM listed diamond mining company, which owns and operates the Kareevlei Diamond Mine in the Kimberley region of South Africa, announced that it has sold the 20.72 carat diamond announced on 27 September 2019 for USD236,000 (USD11,389/carat) in the October tender. This is the highest value achieved for the mine to date for a single stone; the previous record sale was the 24.8 carat stone sold in June 2019 for USD190,000 (USD7,862/carat).

Ingenta (ING) 71.5p £12m

Ingenta plc, a leading provider of innovative content solutions, announced that it has secured 2 further new deals for its Commercial software platform.   The sales are for customers based in the UK and US comprising both the Ingenta Order to Cash and Contract, Rights and Royalties solutions. The combined implementation and licence deals are valued at £425K with total annual recurring fees of approximately £40K.

Sosandar (SOS) 20p £26m

Sosandar, the online women’s fashion brand, announced the following trading update covering the six month period ended 30 September 2019.

The Company expects to report revenue of £2.82m for the period, a 53% increase against the same period in the prior year, reflecting progress made during the year so far, with Q2 up 84% and September up 112% against the same periods in the prior year. The Company is very pleased to report that October is already the first month that its net revenues (post returns) have surpassed £1m.

Safestay (SSTY) 31.8p £20.5m

Safestay, the owner and operator of an international brand of contemporary hostels, announced that it has exchanged contracts to acquire the prime boutique hostel AthenStyle for 1.5m. Completion of the purchase is scheduled for 15 January 2020.

Sutton Harbour Group (SUH) 23p £26.7m

Appointment of Corey Benjamin Beinhaker, age 50, as an Executive Director in the role of Chief Operating Officer with immediate effect. Prior to his involvement with Sutton Harbour Group. Corey Beinhaker worked for IBIB Group Consultants (Israel) Limited from 2010 to 2017 latterly as its chief executive officer w here he, amongst other things, was contract manager  for a number of significant projects including the Tel Aviv Red 10 Line Underground Station

Head Chef:

Derren Nathan
0203 764 2344
derren.nathan@hybridan.com

*A corporate client of Hybridan LLP

Disclaimer

This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.

The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.

The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).

Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.

This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.

In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.

Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.

Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.

Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.

This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.

MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.

Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.

If you would like to unsubscribe, please email enquiries@hybridan.com with “unsubscribe me”.